Relationship Between Lipoprotein(a) Phenotypes and Plaminogen Activator Inhibitor Type 1 in Diabetic Patients

Author： Hernandez C.   Chacon P.   Garca-Pascual L.   Mesa J.   Simo R.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.99, Iss.2, 2000-07, pp. : 119-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein(a) Phenotypes in Patients with Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 3, 2000-04 ,pp. : 135-138

Karger

Access to resources Recommend Favorite

Relationship between Triglycerides and Factor VIIc and Plasminogen Activator Inhibitor Type-1 - Risk and management

By Chadarevian R.   Bruckert E.   Dejager S.   Presberg P.   Turpin G.  

Thrombosis Research, Vol. 96, Iss. 3, 1999-11 ,pp. : 175-182

Elsevier

Access to resources Recommend Favorite

Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models

By Hagiwara H.   Kaizu K.   Uriu K.   Noguchi T.   Takagi I.   Qie Y.L.   Seki T.   Ariga T.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite

Evidence for a relationship between plasminogen activator inhibitor-1 and gamma glutamyl transferase

By Bastard J.-P.   Bruckert E.   Porquet D.   Jardel C.   Ankri A.   Delattre J.   Hainque B.  

Thrombosis Research, Vol. 81, Iss. 2, 1996-01 ,pp. : 271-275

Elsevier

Access to resources Recommend Favorite

Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patients

By Wagner A.M.   Ordonez-Llanos J.   Hernandez M.   Luis Sanchez-Quesada J.   Blanco-Vaca F.   Rigla M.   de Leiva A.   Perez A.  

European Journal of Internal Medicine, Vol. 12, Iss. 6, 2001-12 ,pp. : 496-502

Elsevier

Access to resources Recommend Favorite